The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
Stengel, A, Kern, W, Haferlach, T, Meggendorfer, M, Fasan, A, Haferlach, C
Published in Leukemia (01.03.2017)
Published in Leukemia (01.03.2017)
Get full text
Journal Article
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients
Jeromin, S, Weissmann, S, Haferlach, C, Dicker, F, Bayer, K, Grossmann, V, Alpermann, T, Roller, A, Kohlmann, A, Haferlach, T, Kern, W, Schnittger, S
Published in Leukemia (01.01.2014)
Published in Leukemia (01.01.2014)
Get full text
Journal Article
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Haferlach, T, Nagata, Y, Grossmann, V, Okuno, Y, Bacher, U, Nagae, G, Schnittger, S, Sanada, M, Kon, A, Alpermann, T, Yoshida, K, Roller, A, Nadarajah, N, Shiraishi, Y, Shiozawa, Y, Chiba, K, Tanaka, H, Koeffler, H P, Klein, H-U, Dugas, M, Aburatani, H, Kohlmann, A, Miyano, S, Haferlach, C, Kern, W, Ogawa, S
Published in Leukemia (01.02.2014)
Published in Leukemia (01.02.2014)
Get full text
Journal Article
Landscape of TET2 mutations in acute myeloid leukemia
WEISSMANN, S, ALPERMANN, T, KERN, W, SCHNITTGER, S, KOHLMANN, A, GROSSMANN, V, KOWARSCH, A, NADARAJAH, N, EDER, C, DICKER, F, FASAN, A, HAFERLACH, C, HAFERLACH, T
Published in Leukemia (01.05.2012)
Published in Leukemia (01.05.2012)
Get full text
Journal Article
Subtype-specific patterns of molecular mutations in acute myeloid leukemia
Rose, D, Haferlach, T, Schnittger, S, Perglerová, K, Kern, W, Haferlach, C
Published in Leukemia (01.01.2017)
Published in Leukemia (01.01.2017)
Get full text
Journal Article
The role of different genetic subtypes of CEBPA mutated AML
Fasan, A, Haferlach, C, Alpermann, T, Jeromin, S, Grossmann, V, Eder, C, Weissmann, S, Dicker, F, Kohlmann, A, Schindela, S, Kern, W, Haferlach, T, Schnittger, S
Published in Leukemia (01.04.2014)
Published in Leukemia (01.04.2014)
Get full text
Journal Article
STAT3 mutations are highly specific for large granular lymphocytic leukemia
Fasan, A, Kern, W, Grossmann, V, Haferlach, C, Haferlach, T, Schnittger, S
Published in Leukemia (01.07.2013)
Published in Leukemia (01.07.2013)
Get full text
Journal Article
European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms
Rack, K A, van den Berg, E, Haferlach, C, Beverloo, H B, Costa, D, Espinet, B, Foot, N, Jeffries, S, Martin, K, O'Connor, S, Schoumans, J, Talley, P, Telford, N, Stioui, S, Zemanova, Z, Hastings, R J
Published in Leukemia (01.08.2019)
Published in Leukemia (01.08.2019)
Get full text
Journal Article
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis
Jawhar, M, Schwaab, J, Schnittger, S, Meggendorfer, M, Pfirrmann, M, Sotlar, K, Horny, H-P, Metzgeroth, G, Kluger, S, Naumann, N, Haferlach, C, Haferlach, T, Valent, P, Hofmann, W-K, Fabarius, A, Cross, N C P, Reiter, A
Published in Leukemia (01.01.2016)
Published in Leukemia (01.01.2016)
Get full text
Journal Article
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
Meggendorfer, M, Bacher, U, Alpermann, T, Haferlach, C, Kern, W, Gambacorti-Passerini, C, Haferlach, T, Schnittger, S
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Hehlmann, R, Lauseker, M, Saußele, S, Pfirrmann, M, Krause, S, Kolb, H J, Neubauer, A, Hossfeld, D K, Nerl, C, Gratwohl, A, Baerlocher, G M, Heim, D, Brümmendorf, T H, Fabarius, A, Haferlach, C, Schlegelberger, B, Müller, M C, Jeromin, S, Proetel, U, Kohlbrenner, K, Voskanyan, A, Rinaldetti, S, Seifarth, W, Spieß, B, Balleisen, L, Goebeler, M C, Hänel, M, Ho, A, Dengler, J, Falge, C, Kanz, L, Kremers, S, Burchert, A, Kneba, M, Stegelmann, F, Köhne, C A, Lindemann, H W, Waller, C F, Pfreundschuh, M, Spiekermann, K, Berdel, W E, Müller, L, Edinger, M, Mayer, J, Beelen, D W, Bentz, M, Link, H, Hertenstein, B, Fuchs, R, Wernli, M, Schlegel, F, Schlag, R, de Wit, M, Trümper, L, Hebart, H, Hahn, M, Thomalla, J, Scheid, C, Schafhausen, P, Verbeek, W, Eckart, M J, Gassmann, W, Pezzutto, A, Schenk, M, Brossart, P, Geer, T, Bildat, S, Schäfer, E, Hochhaus, A, Hasford, J
Published in Leukemia (01.11.2017)
Published in Leukemia (01.11.2017)
Get full text
Journal Article
Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML
Stengel, A, Kern, W, Meggendorfer, M, Nadarajah, N, Perglerovà, K, Haferlach, T, Haferlach, C
Published in Leukemia (01.02.2018)
Published in Leukemia (01.02.2018)
Get full text
Journal Article
Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia
SCHNITTGER, S, BACHER, U, KERN, W, ALPERMANN, T, HAFERLACH, C, HAFERLACH, T
Published in Leukemia (01.08.2011)
Published in Leukemia (01.08.2011)
Get full text
Journal Article
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status
Schmidt, M, Rinke, J, Schäfer, V, Schnittger, S, Kohlmann, A, Obstfelder, E, Kunert, C, Ziermann, J, Winkelmann, N, Eigendorff, E, Haferlach, T, Haferlach, C, Hochhaus, A, Ernst, T
Published in Leukemia (01.12.2014)
Published in Leukemia (01.12.2014)
Get full text
Journal Article
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype
HAFERLACH, C, DICKER, F, HERHOLZ, H, SCHNITTGER, S, KERN, W, HAFERLACH, T
Published in Leukemia (01.08.2008)
Published in Leukemia (01.08.2008)
Get full text
Journal Article
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome
Schnittger, S, Eder, C, Jeromin, S, Alpermann, T, Fasan, A, Grossmann, V, Kohlmann, A, Illig, T, Klopp, N, Wichmann, H-E, Kreuzer, K-A, Schmid, C, Staib, P, Peceny, R, Schmitz, N, Kern, W, Haferlach, C, Haferlach, T
Published in Leukemia (01.01.2013)
Published in Leukemia (01.01.2013)
Get full text
Journal Article
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
HANFSTEIN, B, MÜLLER, M. C, KOLB, H.-J, KRAUSE, S. W, HOFMANN, W.-K, SCHUBERT, J, EINSELE, H, DENGLER, J, HÄNEL, M, FALGE, C, KANZ, L, NEUBAUER, A, HEHLMANN, R, KNEBA, M, STEGELMANN, F, PFREUNDSCHUH, M, WALLER, C. F, BRANFORD, S, HUGHES, T. P, SPIEKERMANN, K, BAERLOCHER, G. M, PFIRRMANN, M, HASFORD, J, ERBEN, P, SAUSSELE, S, HOCHHAUS, A, LAUSEKER, M, FABARIUS, A, SCHNITTGER, S, HAFERLACH, C, GÖHRING, G, PROETEL, U
Published in Leukemia (01.09.2012)
Published in Leukemia (01.09.2012)
Get full text
Journal Article